Cardiorespiratory Fitness: A Strong Predictor Of Insulin Resistance Among High-risk Patients Developing Type 2 Diabetes (t2d)

被引：0

作者：

ALduhishy, Anas M. ^{[1
]}

机构：

[1] Univ Dammam, Alkhubar, Saudi Arabia

来源：

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2015年 / 47卷 / 05期

关键词：

D O I：

10.1249/01.mss.0000476743.66890.07

中图分类号：

G8 [体育];

学科分类号：

04 ; 0403 ;

摘要：

454

引用

页码：122 / 122

页数：1

共 50 条

[1] Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance
Silmara AO Leite
Arlene M Monk
Paul A Upham
Antonio R Chacra
Richard M Bergenstal
Diabetology & Metabolic Syndrome, 1
[2] Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance
Leite, Silmara A. O.
Monk, Arlene M.
Upham, Paul A.
Chacra, Antonio R.
Bergenstal, Richard M.
DIABETOLOGY & METABOLIC SYNDROME, 2009, 1
[3] Perception of Risk for Developing Type 2 Diabetes (T2D) among Women With Recent Gestational Diabetes Mellitus (GDM)
Lawrence, Jean M.
Donahoo, William T.
Raebel, Marsha A.
Desai, Jay
Ferrara, Assiamira
Bennett, Wendy T.
Zhang, Jian L.
Newton, Katherine M.
DIABETES, 2013, 62 : A359 - A359
[4] Relationship of Echocardiogram (ECHO) to Cardiorespiratory Fitness (CRF) and Body Composition in Youth with Type 2 Diabetes (T2D) in TODAY
Bacha, Fida
Gidding, Samuel S.
Pyle, Laura
Katz, Lorraine E. L.
Kriska, Andrea M.
Nadeau, Kristen J.
DIABETES, 2014, 63 : A44 - A44
[5] Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria The CHILI T2D Study
Ketelhut, Reinhard
Bramlage, Peter
CLINICAL DRUG INVESTIGATION, 2010, 30 (05) : 301 - 311
[6] Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and MicroalbuminuriaThe CHILI T2D Study
Reinhard Ketelhut
Peter Bramlage
Clinical Drug Investigation, 2010, 30 : 301 - 311
[7] Attitude towards starting insulin therapy in patients with type 2 diabetes (T2D)
Lee, Lauren J.
Zagar, Anthony
Helbers, Lawrence
Jezorwski, John E.
Sun, Peter
Martin, Sherry
DIABETES, 2008, 57 : A516 - A516
[8] The association of fasting plasma glucose (FPG) and health outcomes among type 2 diabetes (T2D) insulin patients
Buchs, Sarah K.
DiBonaventura, Marco
Weatherall, James
Wisniewski, Tami
QUALITY OF LIFE RESEARCH, 2016, 25 : 129 - 129
[9] Mood and cognitive effects of insulin treatment (Tx) in type 2 diabetes (T2D) patients
Cox, Daniel J.
Mccall, Anthony
Kovatchev, Boris
Ilag, Liza L.
Sarwat, Samiha
Tan, Meng H.
DIABETES, 2007, 56 : A496 - A496
[10] U500 Insulin for Insulin Resistant Patients with Type 2 Diabetes (T2D): A Retrospective Analysis
Ziesmer, Anne
Guerra, Patricia R.
George, Karen G.
Dunn, Fredrick L.
DIABETES, 2010, 59 : A202 - A202

← 1 2 3 4 5 →